The authors acknowledge the use of NotebookLM for the initial conceptualisation and visual structuring of Figures 1–3. The generated outputs were critically reviewed, modified, refined, and scientifically interpreted by the authors prior to inclusion in the manuscript.
Author contributions
NP: Conceptualisation, Investigation, Writing—original draft, Writing—review & editing. MH: Writing—review & editing. Both authors read and approved the submitted version.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease.Nat Rev Microbiol. 2021;19:55–71. [DOI] [PubMed]
Duhan P, Gupta B, Ahmed M, Bansal P. Gut microbiome engineering with probiotics: current trends and future directions.Discov Appl Sci. 2025;7:1354. [DOI]
Lee YQ, Choi Y, Park S, Kim S, Lee M, Kim D, et al. Genome-scale metabolic model-guided systematic framework for designing customized live biotherapeutic products.NPJ Syst Biol Appl. 2025;11:73. [DOI] [PubMed] [PMC]
McCarty NS, Ledesma-Amaro R. Synthetic Biology Tools to Engineer Microbial Communities for Biotechnology.Trends Biotechnol. 2019;37:181–97. [DOI] [PubMed] [PMC]
Priyadharshini D, Muthuvel I, Saraswathy S, Kavitha PS, Jegadeeswari V. Precision to plate: AI-driven innovations in fermentation and hyper-personalized diets.Front Nutr. 2025;12:1659511. [DOI] [PubMed] [PMC]
Chemla Y, Sweeney CJ, Wozniak CA, Voigt CA. Design and regulation of engineered bacteria for environmental release.Nat Microbiol. 2025;10:281–300. [DOI] [PubMed]
Zhou Z, Chen X, Sheng H, Shen X, Sun X, Yan Y, et al. Engineering probiotics as living diagnostics and therapeutics for improving human health.Microb Cell Fact. 2020;19:56. [DOI] [PubMed] [PMC]
Prajapati N, Patel J, Singh S, Yadav VK, Joshi C, Patani A, et al. Postbiotic production: harnessing the power of microbial metabolites for health applications.Front Microbiol. 2023;14:1306192. [DOI] [PubMed] [PMC]
Han K, Xu J, Xie F, Crowther J, Moon JJ. Engineering Strategies to Modulate the Gut Microbiome and Immune System.J Immunol. 2024;212:208–15. [DOI] [PubMed] [PMC]
Kim K, Kang M, Cho B. Systems and synthetic biology-driven engineering of live bacterial therapeutics.Front Bioeng Biotechnol. 2023;11:1267378. [DOI] [PubMed] [PMC]
Rutter JW, Dekker L, Owen KA, Barnes CP. Microbiome engineering: engineered live biotherapeutic products for treating human disease.Front Bioeng Biotechnol. 2022;10:1000873. [DOI] [PubMed] [PMC]
Mugwanda K, Hamese S, Zyl WFV, Prinsloo E, Plessis MD, Dicks LMT, et al. Recent advances in genetic tools for engineering probiotic lactic acid bacteria.Biosci Rep. 2023;43:BSR20211299. [DOI] [PubMed] [PMC]
Nazir A, Hussain FHN, Raza A. Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine.Front Bioeng Biotechnol. 2024;12:1511149. [DOI] [PubMed] [PMC]
Abouelela ME, Helmy YA. Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives.Microorganisms. 2024;12:430. [DOI] [PubMed] [PMC]
Sun Z, Harris HMB, McCann A, Guo C, Argimón S, Zhang W, et al. Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera.Nat Commun. 2015;6:8322. [DOI] [PubMed] [PMC]
Pell LG, Horne RG, Huntley S, Rahman H, Kar S, Islam MS, et al. Antimicrobial susceptibilities and comparative whole genome analysis of two isolates of the probiotic bacterium Lactiplantibacillus plantarum, strain ATCC 202195.Sci Rep. 2021;11:15893. [DOI] [PubMed] [PMC]
Armetta JCD. Sequence-guided approaches for the cultivation and engineering of the gut microbiome [dissertation]. Kongens Lyngby: Technical University of Denmark; 2022.
Boyle PM, Silver PA. Parts plus pipes: synthetic biology approaches to metabolic engineering.Metab Eng. 2012;14:223–32. [DOI] [PubMed] [PMC]
Hedin KA. Establishing Saccharomyces boulardii as an advanced microbiome therapeutic platform [dissertation]. Kongens Lyngby: Technical University of Denmark; 2022.
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic.Nat Rev Gastroenterol Hepatol. 2014;11:506–14. [DOI] [PubMed]
Voorhees PJ, Cruz-Teran C, Edelstein J, Lai SK. Challenges & opportunities for phage-based in situ microbiome engineering in the gut.J Control Release. 2020;326:106–19. [DOI] [PubMed]
Patra D. Synthetic Biology-Enabled Engineering of Probiotics for Precision and Targeted Therapeutic Delivery Applications.Exon. 2024;1:54–66. [DOI]
van Pijkeren JP, Barrangou R. Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics.Microbiol Spectr. 2017;5:10.1128/microbiolspec.bad-0013-2016. [DOI] [PubMed] [PMC]
Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K, et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics.Nat Rev Gastroenterol Hepatol. 2020;17:687–701. [DOI] [PubMed] [PMC]
Groisman EA, Han W, Krypotou E. Advancing the fitness of gut commensal bacteria.Science. 2023;382:766–8. [DOI] [PubMed] [PMC]
Zambare V, Md Din MF, Gupta P, Prajapati BG, editors. Advances in Probiotics for Health and Nutrition. London: IntechOpen; 2024. [DOI]
Turroni F, Milani C, Duranti S, Mancabelli L, Mangifesta M, Viappiani A, et al. Deciphering bifidobacterial-mediated metabolic interactions and their impact on gut microbiota by a multi-omics approach.ISME J. 2016;10:1656–68. [DOI] [PubMed] [PMC]
Kvakova M, Bertkova I, Stofilova J, Savidge TC. Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation.Foods. 2021;10:1297. [DOI] [PubMed] [PMC]
Rao AV, Rao L. Probiotics and Prebiotics in Human Nutrition and Health. London: IntechOpen; 2016. [DOI]
Hutkins R, Walter J, Gibson GR, Bedu-Ferrari C, Scott K, Tancredi DJ, et al. Classifying compounds as prebiotics - scientific perspectives and recommendations.Nat Rev Gastroenterol Hepatol. 2025;22:54–70. [DOI] [PubMed]
Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic.Nat Rev Gastroenterol Hepatol. 2019;16:605–16. [DOI] [PubMed]
Yadav M, Sehrawat N, Sharma AK, Kumar S, Singh R, Kumar A, et al. Synbiotics as potent functional food: recent updates on therapeutic potential and mechanistic insight.J Food Sci Technol. 2024;61:1–15. [DOI] [PubMed] [PMC]
Spacova I, Dodiya HB, Happel A, Strain C, Vandenheuvel D, Wang X, et al. Future of Probiotics and Prebiotics and the Implications for Early Career Researchers.Front Microbiol. 2020;11:1400. [DOI] [PubMed] [PMC]
Han S, Treuren WV, Fischer CR, Merrill BD, DeFelice BC, Sanchez JM, et al. A metabolomics pipeline enables mechanistic interrogation of the gut microbiome.Nature. 2021;5:445684. [DOI]
Kwoji ID, Aiyegoro OA, Okpeku M, Adeleke MA. ‘Multi-omics’ data integration: applications in probiotics studies.NPJ Sci Food. 2023;7:25. [DOI] [PubMed] [PMC]
Ezzamouri B, Shoaie S, Ledesma-Amaro R. Synergies of Systems Biology and Synthetic Biology in Human Microbiome Studies.Front Microbiol. 2021;12:681982. [DOI] [PubMed] [PMC]
Jansma J, Aidy SE. Understanding the host-microbe interactions using metabolic modeling.Microbiome. 2021;9:16. [DOI] [PubMed] [PMC]
Chakaroun RM, Olsson LM, Bäckhed F. The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease.Nat Rev Cardiol. 2023;20:217–35. [DOI] [PubMed]
Westfall S, Carracci F, Estill M, Zhao D, Wu Q, Shen L, et al. Optimization of probiotic therapeutics using machine learning in an artificial human gastrointestinal tract.Sci Rep. 2021;11:1067. [DOI] [PubMed] [PMC]
Raparthi M, Maruthi S, Dodda SB, Reddy SRB. AI-Driven Metabolmics for Precision Nutrition: Tailoring Dietary Recommendations based on Individual Health Profiles.EEL. 2022;12:172–9. [DOI]
de Jesus LCL, Lima FA, Coelho-Rocha ND, da Silva TF, Paz J, Azevedo V, et al. Recombinant Probiotics and Microbiota Modulation as a Good Therapy for Diseases Related to the GIT. In: Salanta LC, editor. The Health Benefits of Foods - Current Knowledge and Further Development. London: IntechOpen; 2019. [DOI]
Patel NJ, Hajoori M, Desai P. Evaluating probiotic properties of gut microflora for gut modulation as an adjuvant therapy for Parkinson’s disease.J Future Foods. 2025;5:304–16. [DOI]
Zhu Z, Cheng Y, Liu X, Xu X, Ding W, Ling Z, et al. The microbiota-gut-brain axis in depression: unraveling the relationships and therapeutic opportunities.Front Immunol. 2025;16:1644160. [DOI] [PubMed] [PMC]
Yu Z, Ke L, Lu T, Li L, Gu H, Rao P. Implementing a food first strategy can transform preventive healthcare.NPJ Sci Food. 2024;8:57. [DOI] [PubMed] [PMC]
Food as medicine: translating the evidence.Nat Med. 2023;29:753–54. [DOI] [PubMed]
Ashaolu TJ, Le T. Gut allies against metabolic disorders: the therapeutic promise of probiotics.Folia Microbiol (Praha). 2026;71:47–56. [DOI] [PubMed]
Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity.Nat Rev Endocrinol. 2015;11:577–91. [DOI] [PubMed]
El Hage R, Hernandez-Sanabria E, Calatayud Arroyo M, Van de Wiele T. Supplementation of a propionate-producing consortium improves markers of insulin resistance in an in vitro model of gut-liver axis.Am J Physiol Endocrinol Metab. 2020;318:E742–9. [DOI] [PubMed]
Klimesova K, Whittamore JM, Hatch M. Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria.Urolithiasis. 2015;43:107–17. [DOI] [PubMed] [PMC]
Zhang Y, Zhu X, Yu X, Novák P, Gui Q, Yin K. Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.Front Nutr. 2023;10:1120168. [DOI] [PubMed] [PMC]
Mok K, Tomtong P, Ogawa T, Nagai K, Torrungruang P, Charoensiddhi S, et al. Synbiotic-driven modulation of the gut microbiota and metabolic functions related to obesity: insights from a human gastrointestinal model.BMC Microbiol. 2025;25:250. [DOI] [PubMed] [PMC]
Munshi A, Sharma V. Omics and Edible Vaccines. In: Barh D, Azevedo V, editors. Omics Technologies and Bio-Engineering. Academic Press; 2018. pp. 129–41. [DOI]
Guo T, Gao C, Hao J, Lu X, Xie K, Wang X, et al. Strategy of Developing Oral Vaccine Candidates Against Co-infection of Porcine Diarrhea Viruses Based on a Lactobacillus Delivery System.Front Microbiol. 2022;13:872550. [DOI] [PubMed] [PMC]
Simon A, Colom J, Mazhar S, Khokhlova E, Deaton J, Rea K. Bacillus megaterium Renuspore® as a potential probiotic for gut health and detoxification of unwanted dietary contaminants.Front Microbiol. 2023;14:1125616. [DOI] [PubMed] [PMC]
Kõiv V, Adamberg K, Adamberg S, Sumeri I, Kasvandik S, Kisand V, et al. Microbiome of root vegetables-a source of gluten-degrading bacteria.Appl Microbiol Biotechnol. 2020;104:8871–85. [DOI] [PubMed] [PMC]
Leszczyńska J, Szczepankowska AK, Majak I, Mańkowska D, Smolińska B, Ścieszka S, et al. Reducing Immunoreactivity of Gluten Peptides by Probiotic Lactic Acid Bacteria for Dietary Management of Gluten-Related Diseases.Nutrients. 2024;16:976. [DOI] [PubMed] [PMC]
Committee ES; More S, Bampidis V, Benford D, Bragard C, Halldorsson T, et al. Evaluation of existing guidelines for their adequacy for the food and feed risk assessment of microorganisms obtained through synthetic biology.EFSA J. 2022;20:e07479. [DOI] [PubMed] [PMC]
Wortelboer K, Koopen AM, Herrema H, de Vos WM, Nieuwdorp M, Kemper EM. From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii.Front Med (Lausanne). 2022;9:1077275. [DOI] [PubMed] [PMC]
Group MTI; Barberio D. Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing.Front Microbiomes. 2024;3:1441290. [DOI] [PubMed] [PMC]
Hoffmann SA, Cai Y. Engineering stringent genetic biocontainment of yeast with a protein stability switch.Nat Commun. 2024;15:1060. [DOI] [PubMed] [PMC]
George DR, Danciu M, Davenport PW, Lakin MR, Chappell J, Frow EK. A bumpy road ahead for genetic biocontainment.Nat Commun. 2024;15:650. [DOI] [PubMed] [PMC]
Hoffmann SA, Diggans J, Densmore D, Dai J, Knight T, Leproust E, et al. Safety by design: Biosafety and biosecurity in the age of synthetic genomics.iScience. 2023;26:106165. [DOI] [PubMed] [PMC]
Peixoto RS, Voolstra CR, Sweet M, Duarte CM, Carvalho S, Villela H, et al. Harnessing the microbiome to prevent global biodiversity loss.Nat Microbiol. 2022;7:1726–35. [DOI] [PubMed]
Saxena R, Sharma V, Saxena AR, Patel A. Harnessing AI and Gut Microbiome Research for Precision Health.JAIGS. 2024;3:74. [DOI]
Ratiner K, Ciocan D, Abdeen SK, Elinav E. Utilization of the microbiome in personalized medicine.Nat Rev Microbiol. 2024;22:291–308. [DOI] [PubMed]
Maniya H, Modasiya I, Chauhan M, Mori P, Kumar V. Developing Robust Probiotic Consortia: A Methodological Optimization Approach.Curr Microbiol. 2024;81:407. [DOI] [PubMed]
